Carl Hansen Receives the 2021 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - October 1, 2021) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce Dr. Carl Hansen of AbCellera Biologics ("AbCellera") as the recipient of the 2021 Bloom Burton Award. From the outset of the COVID-19 pandemic, AbCellera moved from initial screening of blood samples to human clinical trials of its antibody treatment for COVID-19 in 90 days - a process that normally takes years. In the same year, AbCellera's COVID-19 drug, bamlanivimab, was partnered with...
2021-10-01 9:48 AM EDT
Three Finalists Announced for the 2021 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - April 27, 2021) - Bloom Burton & Co. is pleased to announce the three finalists for the 2021 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year.The three finalists are, in alphabetical order:Daniel Durocher, PhD: Scientific Co-founder, Repare Therapeutics; Carl Hansen, PhD: Founder and CEO, AbCellera; andHamed Shahbazi: Chairman and CEO,...
2021-04-27 9:00 AM EDT
Richardson Wealth and Bloom Burton & Co. Announce Strategic Alliance to Expand Wealth Solutions in Healthcare Sector
Toronto, Ontario--(Newsfile Corp. - February 9, 2021) - RF Capital Group Inc. (TSX: RCG) ("RF Capital") today announced that its wholly owned subsidiary Richardson Wealth Limited ("Richardson Wealth") and Bloom Burton & Co. Inc. ("Bloom Burton"), two of Canada's premier independent financial services firms, have entered into a strategic alliance dedicated exclusively on the healthcare sector. This strategic alliance helps unlock growth potential for both firms. Richardson Wealth expands an already broad shelf of wealth solutions by providing advisors...
2021-02-09 4:20 PM EST
Bloom Burton & Co. Announces the 2021 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - January 25, 2021) - Bloom Burton & Co. ("Bloom Burton") is excited to announce the launch of the 2021 Bloom Burton Award and the Bloom Burton Award Gala event to be held at the Four Seasons Hotel in Toronto, Ontario, Canada on Thursday, September 30, 2021. Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, investor or policy maker who made the greatest contribution to Canada's innovative healthcare industry in...
2021-01-25 9:30 AM EST
Gordon Keller Receives the 2020 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - November 26, 2020) - Bloom Burton & Co. is pleased to announce Dr. Gordon Keller as the recipient of the 2020 Bloom Burton Award. Dr. Keller's pioneering academic work in the stem cell therapy field led to the founding of BlueRock Therapeutics in 2016, which was ultimately acquired by Bayer for $1 billion in 2019. BlueRock Therapeutics built out a major laboratory in Toronto, where more than 170 world-class scientists have been recruited to bring new...
2020-11-26 7:15 AM EST
The Bloom Burton Healthcare Lending Trust Named Winner in 2020 Canadian Hedge Fund Awards
Toronto, Ontario--(Newsfile Corp. - October 22, 2020) - The Bloom Burton Healthcare Lending Trust (the "Fund") was named a winner in multiple categories of the 2020 Canadian Hedge Fund Awards (CHFA). Bloom Burton Investment Group Inc. is the manager of the Fund and the Bloom Burton Canadian Healthcare Fund, alternative investment funds that focus on investments in the healthcare sector.The Fund, a private debt fund, won two awards in the private debt category:Best 3-Year ReturnBest 5-Year ReturnThe Canadian Hedge...
2020-10-22 7:00 AM EDT
Bloom Burton & Co. Inc. Announces Holdings in Mimi's Rock Corp.
Toronto, Ontario--(Newsfile Corp. - July 10, 2020) - Bloom Burton & Co. Inc. ("Bloom Burton") announces that, today, 720,240 common share purchase warrants of Mimi's Rock Corp. expired unexercised, resulting in a decrease of holdings to below 10% of the outstanding common shares of Mimi's Rock. Prior to the expiry of these warrants, Bloom Burton, together with its joint actors, beneficially owned, directly and indirectly, 3,507,492 shares and 1,479,240 share purchase warrants representing approximately 6.68% of the outstanding shares on...
2020-07-10 5:01 PM EDT
Bloom Burton & Co. Inc. Announces Amendment to Early Warning Report Regarding Mimi's Rock Corp.
Toronto, Ontario--(Newsfile Corp. - July 29, 2019) - Further to its news release issued on July 26, 2019 announcing its holdings in Mimi's Rock Corp. (TSXV: MIMI) ("Mimi"), Bloom Burton & Co. Inc. ("Bloom Burton") has filed an amended and restated early warning report reflecting the correct number of securities it held prior to the acquisition of 200,000 common shares of Mimi on July 4, 2019. Prior to such acquisition, Bloom Burton beneficially owned, directly and indirectly, 2,893,267 common shares...
2019-07-29 7:00 AM EDT
Bloom Burton & Co. Inc. Announces Holdings in Mimi's Rock Corp.
Toronto, Ontario--(Newsfile Corp. - July 26, 2019) - Bloom Burton & Co. Inc. ("Bloom Burton") announces that it beneficially owns, directly and indirectly, 3,231,867 common shares ("shares") and 1,479,240 share purchase warrants of Mimi's Rock Corp. ("Mimi"), each warrant being exercisable for 1.5 shares representing approximately 6.52% of the outstanding shares on a non-diluted basis and approximately 10.53%% on a partially diluted basis. This press release is being issued pursuant to Canadian early warning requirements because of the acquisition by...
2019-07-26 7:14 PM EDT
Bloom Burton & Co. Inc. Announces Holdings in Appili Therapeutics Inc.
Toronto, Ontario--(Newsfile Corp. - June 24, 2019) - Bloom Burton & Co. Inc. ("Bloom Burton") announces that it beneficially owns, directly and indirectly, 14,350,120 Class A common shares ("shares") and 2,200 broker warrants of Appili Therapeutics Inc. ("Appili") representing approximately 42.79% of the outstanding shares on a non-diluted basis and approximately 42.80% on a partially diluted basis. This press release is being issued pursuant to Canadian early warning requirements because of Appili becoming a reporting issuer and the subsequent acquisition...
2019-06-24 7:55 AM EDT